AS

Ashutosh Sanjay Patel

Active Director Director DIN 11704273
DIN 11704273 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Ashutosh Sanjay Patel

Data last updated:

Ashutosh Sanjay Patel is a Director at Velitaas Pharmaceuticals Private Limited (since 2026).

DIN 11704273
Primary Designation Director
First Appointment 07 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 May 20262026Active

Directorship timeline

Open interactive timeline →
Velitaas Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ashutosh Sanjay Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashutosh Sanjay Patel

Ashutosh Sanjay Patel currently holds 1 directorship: Velitaas Pharmaceuticals Private Limited (Director, since 07 May 2026).

Ashutosh Sanjay Patel was first appointed on 07 May 2026 as Director at Velitaas Pharmaceuticals Private Limited.

The current boards of Ashutosh Sanjay Patel's companies include Namrata Yashanand Patil (Velitaas Pharmaceuticals Private Limited), Pooja Dipak Patil (Velitaas Pharmaceuticals Private Limited), Tandra Sunilkumar Bhunia (Velitaas Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available